Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain

NCT: NCT04144972 · RECRUITING

NCT IDNCT04144972
StatusRECRUITING
Start Date2019-10-24
Completion2030-10-24
SponsorUniversity of California, San Francisco (OTHER)
First posted
Last updated

Brief Summary

Chronic pain affects 1 in 4 US adults, and many cases are resistant to almost any treatment. Deep brain stimulation (DBS) holds promise as a new option for patients suffering from treatment-resistant chronic pain, but traditional approaches target only brain regions involved in one aspect of the pain experience and provide continuous 24/7 brain stimulation which may lose effect over time. By developing new technology that targets multiple, complimentary brain regions in an adaptive fashion, the investigators will test a new therapy for chronic pain that has potential for better, more enduring analgesia.

Frequently Asked Questions

What is Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain?

Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain is a clinical trial registered under NCT04144972. Current status: RECRUITING.

What is the status of NCT04144972?

The current status of NCT04144972 (Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain) is: RECRUITING.

When did Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain start?

Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain started on 2019-10-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.